DHR

#112
Danaher Corporation Common Stock
182.6 8 USD
+1.38%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
182.36
183.46
年范围
160.93
242.75
日变化
+1.38%
每月变动
+2.06%
6个月变化
-19.38%
年变化
-4.05%
前一天收盘价
180.1 9
Open
183.1 4
最低价
182.3 6
High
183.4 6
交易量
2 212
展开完整图表 完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 129.3 B
  • Employee 60 K
  • Founded N/A
  • CEO Rainer M. Blair
  • Website www.danaher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BH3JF8
  • Industry 诊断与研究
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
35.04
市销率
5.25

Danaher Corporation Common Stock

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

新闻